Answers are grounded in this paper and cite their sources.
A library of 70 coumarin–piperidine derivatives (Cop1-Cop70) was designed and subjected to molecular docking studies against acetylcholinesterase (AChE; PDB ID: 4EY7) using the Schrödinger software suite. Based on their docking scores, 24 compounds with scores more than -9.50 kcal/mol were selected for ADME prediction using SwissADME. Fourteen derivatives were predicted to cross the blood–brain barrier and were selected for chemical synthesis. The selected compounds were synthesized through cyclization and amide coupling reactions and characterized using FT-IR, 1H NMR, 13C NMR, mass spectrometry and elemental analysis (CHN). Molecular docking analysis provided insights into the predicted binding modes and interactions of the derivatives within the AChE active site. Their inhibitory activity was further assessed using an AChE inhibition assay. Among the synthesized compounds, Cop54 exhibited the highest inhibitory activity, with 72.41% inhibition of AChE. These findings identify Cop54 as a promising lead for further investigation and provide a basis for the development of coumarin–piperidine derivatives as potential AChE inhibitors for Alzheimer’s disease research.
No takes yet. Share an insight, caveat, or question.
Goel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: